Clinical Trials

Status
Title Intervention Sponsor Status
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) Placebo, Sulindac 400 MG Duke University Recruiting
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study Lisinopril, Questionnaire Administration, Biospecimen Collection, Liver Ultrasonographic Elastography, Magnetic Resonance Elastography, Magnetic Resonance Imaging, Proton Density Fat Fraction National Cancer Institute (NCI) Recruiting
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Atorvastatin Calcium, Biopsy of Colon, Biospecimen Collection, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy, Liver Ultrasonographic Elastography, Obeticholic Acid, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Biospecimen Collection, Endoscopic Biopsy, MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP, Questionnaire Administration National Cancer Institute (NCI) Recruiting
GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy, Linaclotide, Plecanatide National Cancer Institute (NCI) Recruiting
Testing Obeticholic Acid for Familial Adenomatous Polyposis Biopsy, Obeticholic Acid, Placebo Administration, Biospecimen Collection, Gastrointestinal Endoscopy, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5, Biopsy, Biospecimen Collection, Colonoscopy, Nogapendekin Alfa, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Recruiting